Zylox-Tonbridge Medical (02190) Announces January 2026 Share Capital and Public Float Status

Bulletin Express02-03

Zylox-Tonbridge Medical Technology Co., Ltd. (02190) released its monthly return for the period ended 31 January 2026. The total authorised share capital remained at RMB 344,132,001, comprising 336,350,744 H shares and 7,781,257 Domestic Shares at a par value of RMB 1 each.

The issued H shares totaled 329,504,613 (excluding treasury shares), with 6,846,131 shares held in treasury, leaving no change from the previous month. The publicly listed H shares satisfied the 25% public float requirement as stipulated by the applicable listing rules. Domestic Shares stood at 7,781,257, also unchanged over the reporting period.

In addition, information was provided on an existing share award scheme adopted on 19 December 2024, whereby 861,939 shares are available for issuance or transfer out of treasury under that arrangement. No other share options, warrants, or convertibles were disclosed, and there were no additional movements in the issued or treasury shares during January 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115065970?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115065970","market":"us","top_or_hot":-1,"title":"Zylox-Tonbridge Medical (02190) Announces January 2026 Share Capital and Public Float Status","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (02190) released its monthly return for the period ended 31 January 2026. The total authorised share capital remained at RMB 344,132,001, comprising 336,350,744 H shares and 7,781,257 Domestic Shares at a par value of RMB 1 each.</p>\n<p>The issued H shares totaled 329,504,613 (excluding treasury shares), with 6,846,131 shares held in treasury, leaving no change from the previous month. The publicly listed H shares satisfied the 25% public float requirement as stipulated by the applicable listing rules. Domestic Shares stood at 7,781,257, also unchanged over the reporting period.</p>\n<p>In addition, information was provided on an existing share award scheme adopted on 19 December 2024, whereby 861,939 shares are available for issuance or transfer out of treasury under that arrangement. No other share options, warrants, or convertibles were disclosed, and there were no additional movements in the issued or treasury shares during January 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Medical (02190) Announces January 2026 Share Capital and Public Float Status</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Medical (02190) Announces January 2026 Share Capital and Public Float Status\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-03 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (02190) released its monthly return for the period ended 31 January 2026. The total authorised share capital remained at RMB 344,132,001, comprising 336,350,744 H shares and 7,781,257 Domestic Shares at a par value of RMB 1 each.</p>\n<p>The issued H shares totaled 329,504,613 (excluding treasury shares), with 6,846,131 shares held in treasury, leaving no change from the previous month. The publicly listed H shares satisfied the 25% public float requirement as stipulated by the applicable listing rules. Domestic Shares stood at 7,781,257, also unchanged over the reporting period.</p>\n<p>In addition, information was provided on an existing share award scheme adopted on 19 December 2024, whereby 861,939 shares are available for issuance or transfer out of treasury under that arrangement. No other share options, warrants, or convertibles were disclosed, and there were no additional movements in the issued or treasury shares during January 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1115065970","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115065970","pubTimestamp":1770110739,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190) released its monthly return for the period ended 31 January 2026. The total authorised share capital remained at RMB 344,132,001, comprising...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"Zylox-Tonbridge Medical(02190)公布2026年1月股本及公众持股量情况","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190) released its monthly return for the period ended 31 January 2026. The total authorised share capital remained at RMB 344,132,001, comprising 336,350,744 H shares and 7,781,257 Domestic Shares at a par value of RMB 1 each.\nThe issued H shares totaled 329,504,613 (excluding treasury shares), with 6,846,131 shares held in treasury, leaving no change from the previous month. The publicly listed H shares satisfied the 25% public float requirement as stipulated by the applicable listing rules. Domestic Shares stood at 7,781,257, also unchanged over the reporting period.\nIn addition, information was provided on an existing share award scheme adopted on 19 December 2024, whereby 861,939 shares are available for issuance or transfer out of treasury under that arrangement. No other share options, warrants, or convertibles were disclosed, and there were no additional movements in the issued or treasury shares during January 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115065970","isCrawlerRequest":true}